Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer.

Zhang, J-L; Yao, Q; Chen Y Wang, J-H; Wang, H; Fan, Q; Ling, R; Yi, J; Wang, L

Zhang, J-L; Yao, Q; Chen Y Wang, J-H; Wang, H; Fan, Q; Ling, R; Yi, J; Wang, L.

Affiliation

Zhang JL; Xijing Hospital Vascular Endocrine Surgery, Xi'an, China zhangjuliang_l@yeah.net.
Yao Q; Xijing Hospital Vascular Endocrine Surgery, Xi'an, China.
Chen Y Wang JH; Xijing Hospital Vascular Endocrine Surgery, Xi'an, China.
Wang H; Xijing Hospital Vascular Endocrine Surgery, Xi'an, China.
Fan Q; Xijing Hospital Vascular Endocrine Surgery, Xi'an, China.
Ling R; Xijing Hospital Vascular Endocrine Surgery, Xi'an, China.
Yi J; Xijing Hospital Vascular Endocrine Surgery, Xi'an, China.
Wang L; Xijing Hospital Vascular Endocrine Surgery, Xi'an, China.

Genet Mol Res ; 14(1): 2099-103, 2015 Mar 20.

Article de En | MEDLINE | ID: mdl-25867356

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Trastuzumab / Cellules tumorales circulantes / Antinéoplasiques Type d'étude: Prognostic_studies Limites: Female / Humans Langue: En Journal: Genet Mol Res Sujet du journal: BIOLOGIA MOLECULAR / GENETICA Année: 2015 Type de document: Article Pays d'affiliation: Chine Pays de publication: Brésil

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google